Shenzhen Xitao Network Technology Co., Ltd. (Chinese: 深圳溪淘网络科技有限公司; "Xitao") is a Chinese company registered in Shenzhen, Guangdong. Its stated business scope covers internet technology development, online commerce, domestic trade, and import/export. English-language corporate information is sparse: the Chinese registry aggregator Qichacha lists a "Shenzhen Xitao Network Technology" entity incorporated 2 December 2014 with registered capital of RMB 60 million and fewer than 50 insured employees, but court filings give a different Unified Social Credit Code, so the exact registration record cannot be confirmed. Ownership, revenue, and headcount are not independently verifiable, and it is not a separately branded public company.
Xitao has no verifiable stand-alone product line. In litigation filings it is described as "a connected company of Shenzhen Root Technology Co., Ltd." and "a post-importation distributor through Alibaba.com" of the Momcozy S12 Pro, S12, S9 Pro, S9, M1, and M5 wearable breast pumps. Those products belong to the Shenzhen-based Momcozy group (Shenzhen Root, Hong Kong Lute, Conglin, Jinruihang, Lutejiacheng), a private consumer mother-and-baby business selling wearable breast pumps, nursing and pumping bras, baby monitors, and maternity products.
Litigation posture: Xitao is not an NPE or shell licensor. It has one tracked case, as a plaintiff, in the U.S. District Court for the Western District of Washington, Seattle Division — not a patent-plaintiff haven such as the Eastern District of Texas. Its single appearance does not fit the NPE pattern (many plaintiff suits, zero defendant suits).
Notable case: Shenzhen Root Technology Co., Ltd. et al. v. Chiaro Technology, Ltd. d/b/a Elvie (2:23-cv-00631-KKE, filed 28 April 2023) began as an action by the Momcozy entities against UK breast-pump maker Elvie, which counterclaimed for infringement of U.S. breast-pump patents ('893, '380, '454, '381). Elvie added Xitao as a counterclaim defendant in 2024 after Momcozy disclosed Xitao's distribution role, so Xitao appears in the caption as a plaintiff/counterclaim defendant rather than as a patent owner asserting a portfolio. The case was stayed in April 2025 pending Chiaro's Delaware bankruptcy proceeding, with a proposed consent judgment/dismissal filed in January 2026. Parallel PTAB proceedings (e.g., IPR2024-00953, IPR2025-00554) challenged the asserted Elvie patents.